DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Sep 11, 2024 8-K
8-K Sep 5, 2024 8-K
SC 13G/A Aug 29, 2024
3 Aug 16, 2024 3
10-Q Aug 12, 2024 10-Q
SC 13D/A Jun 24, 2024 SC 13D/A
8-K Jun 21, 2024 8-K
4 Jun 21, 2024 4
4 Jun 21, 2024 4
4 Jun 21, 2024 4
4 Jun 21, 2024 4
4 Jun 21, 2024 4
10-Q Apr 29, 2024 10-Q
DEF 14A Apr 29, 2024 DEF 14A
PRE 14A Apr 16, 2024 PRE 14A
8-K Mar 26, 2024 8-K
S-8 Mar 8, 2024 S-8
10-K Mar 8, 2024 10-K
SCHEDULE 13G/A Feb 9, 2024
4 Jan 5, 2024 4
4 Jan 5, 2024 4
4 Jan 5, 2024 4
8-K Dec 21, 2023 8-K
10-Q Nov 6, 2023 10-Q
8-K Oct 23, 2023 8-K
← Newer Page 6 of 15 · 351 filings Older →